Armata Pharmaceuticals, Inc.
ARMP- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000921114
No open-market purchases or sales by Armata Pharmaceuticals, Inc. insiders were filed in the last 90 days; 53 institutions reported holding it in 13F filings for Q2 2026, worth $32.3M in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Armata Pharmaceuticals, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 20
- −1 vs. Q2 2021
- Shares held
- 1.19M
- +35.3K (+3.1%) vs. Q2 2021
- Total value
- $4.32M
- −$277.0K (−6.0%) vs. Q2 2021
- New holders
- 0
- 8 more added
- Sold out
- 1
- 5 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ARMP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 53 | $32.3M |
| Q1 2026 | 45 | $40.2M |
| Q4 2025 | 36 | $7.85M |
| Q3 2025 | 28 | $2.27M |
| Q2 2025 | 29 | $1.40M |
| Q1 2025 | 26 | $1.08M |
| Q4 2024 | 24 | $2.57M |
| Q3 2024 | 24 | $3.28M |
| Q2 2024 | 23 | $3.86M |
| Q1 2024 | 24 | $5.93M |
| Q4 2023 | 25 | $4.17M |
| Q3 2023 | 23 | $3.85M |
| Q2 2023 | 22 | $1.35M |
| Q1 2023 | 23 | $2.06M |
| Q4 2022 | 26 | $1.61M |
| Q3 2022 | 20 | $5.73M |
| Q2 2022 | 19 | $5.25M |
| Q1 2022 | 20 | $6.61M |
| Q4 2021 | 17 | $7.25M |
| Q3 2021 | 20 | $4.32M |
| Q2 2021 | 21 | $4.59M |
| Q1 2021 | 23 | $5.62M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Armata Pharmaceuticals, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bank of America Corp | 633,944 | $2.29M | 0.00% | −1530.0% | Reduced |
| Vanguard Group Inc | 168,658 | $610.0K | 0.00% | +1,280+0.8% | Added |
| Bridgeway Capital Management, LLC | 122,400 | $443.0K | 0.01% | +9,000+7.9% | Added |
| Renaissance Technologies LLC | 106,092 | $384.0K | 0.00% | −10,604−9.1% | Reduced |
| Edgewood Management LLC | 50,000 | $181.0K | 0.00% | 00.0% | Unchanged |
| Synovus Financial Corp | 48,060 | $174.0K | 0.00% | +25,000+108.4% | Added |
| BlackRock Inc. | 20,571 | $74.0K | 0.00% | +18,570+928.0% | Added |
| SeaCrest Wealth Management, LLC | 13,500 | $49.0K | 0.01% | 00.0% | Unchanged |
| Citadel Advisors LLC | 11,783 | $43.0K | 0.00% | +910+8.4% | Added |
| Geode Capital Management, LLC | 10,188 | $36.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 2,902 | $11.0K | 0.00% | +1,436+98.0% | Added |
| Morgan Stanley | 1,143 | $4.00K | 0.00% | −849−42.6% | Reduced |
| Sandy Spring Bank | 1,082 | $4.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 866 | $3.00K | 0.00% | +808+1,393.1% | Added |
| Northwestern Mutual Wealth Management Co | 571 | $2.00K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 449 | $2.00K | 0.00% | −35−7.2% | Reduced |
| Wells Fargo & Company | 61 | $0 | 0.00% | +12+24.5% | Added |
| Harbour Investments, Inc. | 21 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 43 | $0 | 0.00% | −2−4.4% | Reduced |
| TCI Wealth Advisors, Inc. | 100 | $0 | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 0 | $0 | 0.00% | −10,055−100.0% | Sold out |